Viz.ai is an AI healthcare company transforming how critical conditions are detected and treated. Its platform connects doctors instantly, streamlines communication, and enables faster decisions. With FDA-cleared AI tools and strong hospital partnerships, Viz.ai helps care teams improve patient outcomes and deliver timely, life-saving treatment.
Viz.ai is a healthcare technology company based in the USA that has its focus on using artificial intelligence to improve care coordination and fast detection of critical medical conditions. The company’s diagnosis solutions based on the latest AI technology analyze medical data to detect life-threatening conditions, automatically notifying the specialists for quicker diagnosis and getting treatment on time.
It merges smart algorithms with togetherness in real time in order to help health care providers organize their work more easily, cut the time down, and increase the quality of the patients’ lives. Its inventive method keeps on being a pioneer in making new levels in developing employing AI for healthcare and operational efficiency.
| Legal Name | Viz.ai Inc. |
| Headquarters | San Francisco, California, United States |
| Business Model | B2B |
| Founding Date | 2016 |
| No. of Employees | Approx 325 (As of 2025) |
The company offers Viz.ai One®, Viz Assist, Viz Neuro Suite, Viz Vascular Suite, Viz Cardio Suite, Viz Trauma Suite, Viz Radiology Suite, Care Coordination Software, AI-based medical imaging analysis, real-time clinical communication, cloud integration, life sciences solutions, and clinical research support.
| Chris Mansi, MD, MBA | Chief Executive Officer & Co-Founder |
| Jieun Choe | Chief Operating Officer |
| Mike Herring | Chief Financial Officer |
| Andrew M. Ibrahim, MD, MSc, FACS | Chief Clinical Officer |
| David Kizner | General Counsel & Chief Privacy Officer |
| Oded Cohen | Vice President, R&D and Israel General Manager |
| Dawn Sprague | Vice President, People |
| Steve Sweeny | Vice President, Business Development & Strategy |
Viz.ai earns revenue through subscriptions with hospitals and health systems, and strategic partnerships with pharmaceutical and medical-device companies.
Client Segments: Hospitals, health systems, and life-science companies.
Target Companies: Healthcare providers and life-science firms seeking AI-driven solutions for diagnostics and care coordination.
Target Geography: Primarily North America and Europe, with gradual expansion into other global markets.